Position in ATYR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$68,980
-$73,499 QoQ
Shares Held
88,436
-51.4% QoQ
Ownership
0.090%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#28
of 109 holders
Holding Since
Mar 2020
6 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in ATYR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026VICTORY CAPITAL MANAGEMENT INC holds $2,020,556,215 across 156 Biotechnology names. ATYR ranks #127 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,888,521 | $843,300,167 | |
| 2 | RPRX |
Royalty Pharma plc
|
3,853,808 | $184,867,169 | |
| 3 | INCY |
Incyte Corp
|
1,742,870 | $164,038,924 | |
| 4 | REGN |
Regeneron Pharmaceuticals, Inc.
|
129,074 | $99,727,735 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
195,937 | $64,829,675 | |
| 6 | INSM |
INSMED Inc
|
396,245 | $64,793,982 | |
| 7 | LGND |
Ligand Pharmaceuticals Inc
|
303,224 | $60,538,671 | |
| 8 | JAZZ |
Jazz Pharmaceuticals plc
|
256,598 | $48,509,851 |
All Filings in ATYR
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $68,980 | 88,436 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $142,479 | 181,966 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $139,018 | 192,813 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $52,028 | 10,262 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $36,699 | 10,138 | Shares | Sole | 2025-02-06 | |
| 2020-03-31 | $3,642 | 1,301 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||